CD3 collaboration

CD3 (Centre for Drug Design and Discovery) is a specialized drug discovery center and investment fund based in Leuven, Belgium, established as a partnership between KU Leuven and the European Investment Fund. The organization bridges the gap between innovative academic research and the pharmaceutical industry by providing the necessary expertise and financial resources to transform fundamental biological insights into viable drug candidates. CD3 focuses on developing small molecules and biologics across various therapeutic areas, including oncology, inflammation, and infectious diseases. By collaborating with academic groups and industry partners, CD3 facilitates the translation of early-stage research into clinical-ready assets and spin-off companies.